Email this article 
Hide
Show all
OPEN ACCESS | 
PEER-REVIEWED |
RESEARCH ARTICLE
|
DOWNLOAD PDF
|
VIEW FULL-TEXT PDF
| TOTAL VIEWS
Synthesis of some pyridyl and cyclohexyl substituted 1,2,4 triazole, 1,3,4-thiadiazole and 1,3,4-oxadiazole derivatives
Sattar Ebrahimi (1,*)
(1) Department of Chemistry, Islamic Azad University, Malayer Branch, IR-65718-117, Iran
(*) Corresponding Author
Received: 16 Apr 2010 | Revised: 13 Aug 2010 | Accepted: 26 Sep 2010 | Published: 22 Dec 2010 | Issue Date: December 2010
Abstract
New 1,2,4-triazoles (4a-c), 1,3,4-thiadiazoles (5a-c) and 1,3,4-oxadiazoles (6a-c) containing isomeric pyridyl and cyclohexyl were synthesized by intramolecular cyclization of 1,4-disubstituted thiosemicarbazides (3a-c) in alkaline media, acid and neutral condition respectively. The chemical structures of newly synthesized compounds were established with help of FT-IR, 1H-NMR and mass spectral data.
Announcements
Our editors have decided to support scientists to publish their manuscripts in European Journal of Chemistry without any financial constraints.
1- The article processing fee will not be charged from the articles containing the single-crystal structure characterization or a DFT study between September 15, 2023 and October 31, 2023 (Voucher code: FALL2023).
2. A 50% discount will be applied to the article processing fee for submissions made between September 15, 2023 and October 31, 2023 by authors who have at least one publication in the European Journal of Chemistry (Voucher code: AUTHOR-3-2023).
3. Young writers will not be charged for the article processing fee between September 15, 2023 and October 31, 2023 (Voucher code: YOUNG2023).
Editor-in-Chief
European Journal of Chemistry
Keywords
Full Text:
PDF
DOI: 10.5155/eurjchem.1.4.322-324.65
Links for Article
| | | | | | |
| | | | | | |
| | | |
Related Articles
Article Metrics
This Abstract was viewed 1466 times |
PDF Article downloaded 613 times
Citations
[1]. Noor M. Nasir, Tahseen A. Alsalim, Amr Ahmed El-Arabey, Mohnad Abdalla
Anticancer, antioxidant activities and molecular docking study of thiazolidine-4-one and thiadiazol derivatives
Journal of Biomolecular Structure and Dynamics 41(9), 3976, 2023
DOI: 10.1080/07391102.2022.2060306
[2]. Rana M. El-Masry, Hanan H. Kadry, Azza T. Taher, Sahar M. Abou-Seri
Comparative Study of the Synthetic Approaches and Biological Activities of the Bioisosteres of 1,3,4-Oxadiazoles and 1,3,4-Thiadiazoles over the Past Decade
Molecules 27(9), 2709, 2022
DOI: 10.3390/molecules27092709
[3]. Hossein Pasha Ebrahimi, Jabbar S. Hadi, Tahseen A. Alsalim, Thaer S. Ghali, Zeinab Bolandnazar
A novel series of thiosemicarbazone drugs: From synthesis to structure
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 137, 1067, 2015
DOI: 10.1016/j.saa.2014.08.146
[4]. Mashooq Ahmad Bhat, Mohamed A. Al-Omar, Ahmed M. Naglah, Mohamed M. Abdulla, Hoong-Kun Fun
Synthesis and antitumor activity of 4-cyclohexyl/aryl-5-(pyridin-4-yl)-2,4-dihydro-3H-1,2,4-triazole-3-thiones
Medicinal Chemistry Research 24(4), 1558, 2015
DOI: 10.1007/s00044-014-1216-5
[5]. Qiaoling Liu, Huizhi Du, Xiaoze Ren, Wei Bian, Li Fan, Shaomin Shuang, Chuan Dong, Qin Hu, Martin M. F. Choi
Design of Ratiometric Emission Probe with Visible Light Excitation for Determination of Ca2+ in Living Cells
Analytical Chemistry 86(16), 8025, 2014
DOI: 10.1021/ac5022002
References
[1]. Suresh Kumar, G. V.; Rajendraprasad, Y.; Mallikarjuna, B. P.; Chandrashekar, S. M.; Kistayya, C. Eur. J. Med. Chem. 2010, 45, 2063-2074.
doi:10.1016/j.ejmech.2010.01.045
PMid:20149496
[2]. Mallikarjuna, B. P.; Sastry, B. S.; Suresh Kumar, G. V.; Rajendraprasad, Y.; Chandrashekar, S. M.; Sathisha, K. Eur. J. Med. Chem. 2009, 44, 4739-4746.
doi:10.1016/j.ejmech.2009.06.008
PMid:19589626
[3]. Onkol, T.; Cakir, B.; Sahin, M. F. Turk. J. Chem. 2004, 28, 461-466.
[4]. Schenone, S.; Bruno, O.; Ranise, A.; Bondavalli, F.; Filippeli, W.; Falcone, G.; Giordano, L.; Vitelli, M. R. Bioorg. Med. Chem. 2001, 9, 2149-2153.
doi:10.1016/S0968-0896(01)00121-3
[5]. Holla, B. S.; Gonsalves, R.; Shenoy, S. Eur. J. Med. Chem. 2000, 35, 267– 271.
doi:10.1016/S0223-5234(00)00154-9
[6]. Gokce. M.; Cakir, B.; Erol, K.; Sahin, M. F. Arch. Pharm. 2001, 334, 279-283.
[7]. Laddi, U. V.; Desai, S. R.; Bennur, R. S.; Bennur, S. C. Ind. J. Heterocycl. Chem. 2002, 11, 319–322.
[8]. Sahin, G.; Palaska, E.; Melike Ekizoglu, O. M. Il Farmaco 2002, 57, 539–545.
doi:10.1016/S0014-827X(02)01245-4
[9]. Li, Z.; Gu, Z.; Yin, K.; Zhang, R.; Deng, Q.; Xiang, J. Eur. J. Med. Chem. 2009, 44, 4716-4720.
doi:10.1016/j.ejmech.2009.05.030
PMid:19560842
[10]. Ali, T. A.; El-Kazak, A. M. Eur. J. Chem. 2010, 1(1), 6-11.
doi:10.5155/eurjchem.1.1.6-11.12
[11]. Rollas, S.; Kalyoncuoğlu, N.; Sür-Altiner, D.; Yegenoğlu, Y. Pharmazie 1993, 48, 308-309.
PMid:8321884
[12]. Holla, B. S.; Rao, B. S.; Sarojini, B. K.; Akberali, P. M. Eur. J. Med. Chem. 2004, 39, 777-783.
doi:10.1016/j.ejmech.2004.06.001
PMid:15337290
[13]. Duran, A.; Dogan, H. N.; Rollas S.; Farmaco 2002, 57, 559-564.
doi:10.1016/S0014-827X(02)01248-X
[14]. Sadana, A. K.; Mirza, Y.; Aneja, K. R.; Prakash, O. Eur. J. Med. Chem. 2003, 38, 533-538.
doi:10.1016/S0223-5234(03)00061-8
[15]. Vu, C. B.; Shields, P.; Peng, B.; Kumaravel, G.; Jin, X.; Phadke, D.; Wang, J.; Engber, T.; Ayyub, E.; Petter, R. Bioorg. Med. Chem. Lett. 2004, 14, 4835-838.
doi:10.1016/j.bmcl.2004.07.048
[16]. Ilango, K.; Valentina, P. Eur. J. Chem. 2010, 1(1), 50-53.
doi:10.5155/eurjchem.1.1.50-53.4
[17]. Foroughifar, N.; Mobinikhaledi, A.; Ebrahimi, S. Synthesis 2009, 15, 2557-2560.
doi:10.1055/s-0029-1217398
[18]. Mobinikhaledi, A.; Foroughifar, N.; Khanpour, M.; Ebrahimi, S. Eur. J. Chem. 2010, 1(1), 33-36.
doi:10.5155/eurjchem.1.1.33-36.5
[19]. Foroughifar, N.; Mobinikhaledi, A.; Ebrahimi, S.; Moghanian, H.; Bodaghi Fard, M. A.; Kalhor, M. Tetrahedron Lett. 2009, 50, 836-839.
doi:10.1016/j.tetlet.2008.12.014
[20]. Foroughifar, N.; Mobinikhaledi, A.; Ebrahimi, S.; Bodaghi Fard, M. A.; Moghanian, M. J. Chin. Chem. Soc. 2009, 56, 1043-1047.
[21]. Foroughifar, N.; Mobinikhaledi, A.; Ebrahimi, S. Synthetic Commun. 2010, 40, 2421-2428.
doi:10.1080/00397910903261387
[22]. Zamani, Kh.; Faghihi, Kh.; Tofighi, T. Turk. J. Chem. 2004, 28, 95-100.
How to cite
The other citation formats (EndNote | Reference Manager | ProCite | BibTeX | RefWorks) for this article can be found online at: How to cite item
DOI Link: https://doi.org/10.5155/eurjchem.1.4.322-324.65
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
Save to Zotero
Save to Mendeley
European Journal of Chemistry 2010, 1(4), 322-324 | doi: https://doi.org/10.5155/eurjchem.1.4.322-324.65 | Get rights and content
Refbacks
- There are currently no refbacks.
Copyright (c)
© Copyright 2010 - 2023 • Atlanta Publishing House LLC • All Right Reserved.
The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.
Copyright 2010-2023 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 2850 Smith Ridge Trce Peachtree Cor GA 30071-2636, USA. Registered in USA.